EDBI joins investors in US$500m funding for US biotech unicorn
Singapore
EDBI, the investment arm of the Singapore Economic Development Board, has joined a group of investors in a US$500 million funding round for US biotech Moderna Therapeutics.
Other new investors include a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA), BB Biotech AG, Julius Baer and Sequoia Capital China. Existing investors that also participated in this round include Fidelity Management & Research Company, Pictet, Viking Global Investors, ArrowMark Partners and Alexandria Venture Investments.
TRENDING NOW
He built the Vingroup empire. Now South-east Asia’s richest man is handing some key roles to his sons
Floods compound Philippine growth woes from public-works scandal
Tokyo reverses baby bust with AI matchmaking and generous subsidies
More interest in ETFs, low-cost funds but Singapore still lacks pressure to further lower fund fees
